Nov 09, 2023 8:15am EST Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas
Nov 01, 2023 8:15am EDT Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders
Sep 06, 2023 8:15am EDT Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 17, 2023 8:05am EDT Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care
Aug 10, 2023 4:15pm EDT Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference
Aug 08, 2023 8:15am EDT Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
May 22, 2023 8:05am EDT Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress
May 18, 2023 8:00am EDT Processa Pharmaceuticals to Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based on FDA Guidance and Project Optimus Oncology Initiative